Levothyroxine Serb (Levothyroxine Sodium)

Levothyroxine sodium provides the body with synthetic thyroxine (T4). After injection, it is converted to the active hormone triiodothyronine (T3) inside cells, where it binds nuclear thyroid receptors and regulates gene expression that controls metabolism, growth, and protein synthesis, thereby restoring normal thyroid function.

The appropriate dose of Levothyroxine Serb is individualized by the prescribing clinician based on the patient’s age, weight, cardiac status, and laboratory values such as serum TSH and free T4. No fixed dosing regimen is provided here; the prescriber determines the exact amount and frequency.

Safety data for Levothyroxine Serb in pregnancy and lactation are limited. Thyroid hormone replacement is often required during pregnancy, but the decision to use this product should be made after a careful risk‑benefit assessment by the treating physician. Breastfeeding mothers should also consult their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Levothyroxine Serb. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where applicable) and necessary import documentation.

Levothyroxine Serb is a synthetic T4 formulation, similar in potency to other levothyroxine products but supplied as an injectable dosage form. Compared with oral tablets, the injection provides rapid and reliable bioavailability, which can be advantageous in patients with malabsorption or when immediate hormone replacement is required.

Levothyroxine Serb should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain potency throughout its shelf life.

The medication is given by a healthcare professional as an intramuscular or intravenous injection. The route, injection site and volume are determined by the prescribing clinician based on the patient’s clinical condition and dosing requirements.

Serious adverse events include cardiac arrhythmias, angina, myocardial infarction, and severe allergic reactions such as anaphylaxis. These risks are higher in patients with pre‑existing heart disease, uncontrolled hypertension, or known hypersensitivity to levothyroxine.

Levothyroxine Serb is contraindicated in individuals with known hypersensitivity to levothyroxine sodium, untreated adrenal insufficiency, acute myocardial infarction, or uncontrolled thyrotoxicosis. Patients with these conditions should avoid the product or seek alternative therapy under medical supervision.